The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
None to date. This competitive grant program is a new initiative under the 2002 Reauthorization of the Special Diabetes Program for Indians grant program, Public Law 107-360.
Uses and Use Restrictions
Funds (including direct costs and allowable indirect costs) may be used only for expenses clearly related and necessary to carry out approved activities that will support the implementation and evaluation of demonstration projects under this competitive grant program.
Applicants eligible to receive an award under this announcement are SDPI grant recipients.
The applicant must be one of the following entities: IHS hospital or clinic, federally recognized Tribes, Title V Urban Indian Health Programs or consortia of any of the above.
A SDPI grant recipient can apply only once as a single entity or as part of consortia.
An application submitted by consortia of SDPI grant recipients must be submitted by one of the SDPI grant recipients sanctioned as the principal applicant.
A letter of support must be included in the application from each SDPI grantee the principle applicant is representing.
The letter must specifically state that the principal applicant is officially representing that SDPI grantee in this application.
Applicants for consortia who do not submit these letters of support at the time of the application receipt date will not be reviewed and are ineligible for the award.
Smaller applicants are encouraged to apply as part of consortia, especially their diabetes registry is less than 250.
Applicants are strongly encouraged to establish eligibility of their proposed applications prior to submission.
Inquires about eligibility should be addressed to Mary Tso, SDPI Grants Specialist, IHS National Diabetes Program at 505-248-4182; email to email@example.com.
Applicants that are not SDPI grant recipients are not eligible.
Non-profit tribal organizations or national/area health boards are not eligible, consistent with recent tribal consultation on this issue.
Applications that do not meet these eligibility requirements will be returned to the applicant without further review.
American Indians and Alaska Natives will be the ultimate beneficiaries of the funded demonstration projects through either prevention or direct treatment services.
Costs will be determined in accordance with OMB Circular No. A-87, "Cost Principles for State, Local and Indian Tribal Governments" or OMB Circular No. A-122, "Cost Principles for Non-Profit Organizations."
Aplication and Award Process
This program is excluded from coverage under E.O.
12372, "Intergovernmental Review of Federal Programs." A State approval is not required.
Applications can be found in the grants.gov. Applications will also be available on request from the IHS National Diabetes Program at the following address: 5300 Homestead Road, NE, Albuquerque, NM 87110. Telephone: (505) 248-4182, fax 505-248-4188, email address: firstname.lastname@example.org. The application will be posted on the IHS National Diabetes Program web site at www.ihs.gov/medicalprograms/diabetes and on the HHS Grants web site at www.grants.gov on or before June 1, 2005. Applicants may submit one application for one or both demonstration projects. A separate application is required for each demonstration project. Applicants will be funded for only one project (primary prevention of diabetes or prevention of cardiovascular disease in people with diabetes). Tribal Approval of Application/Letter of Support: It is the policy of the IHS that all projects involving AIAN tribes be approved by the Tribal governments with jurisdiction. Therefore, the following documentation is required as part of this application: 1) For federally recognized Indian tribe - a resolution of support from the Tribal government must be a part of the application. Applications that involve more than one Indian tribe must include resolutions of support from all participating tribes. 2) For an eligible consortium of tribes - a resolution of support from each tribe of the consortium must be included. 3) For Title V Urban Indian Health Programs - a letter of support from the program's board must be included. 4) For IHS hospitals or clinics - a letter of support from the Service Unit Director or Chief Executive Officer must be included. 5) For all applicants - letters of support from all partners and collaborating entities. The preferred method for receipt of applications is electronic submission through Grants.gov. However, should any technical problems arise regarding the submission, please contact Grants.gov Customer Support at 1-800-518-4726 or email@example.com. The Contact Center hours of operation are Monday-Friday from 7:00 a.m. to 9:00 p.m. (Eastern Standard Time). If you require additional assistance please contact Michelle G. Bulls, Grants Policy Officer; Telephone: (301) 443-6528 at least fifteen days prior to the application deadline. To submit an application electronically, please use the http://www.Grants.gov apply site. Download a copy of the application package, on the Grants.gov website, complete it offline and then upload and submit the application via the Grants.gov site. You may not e-mail an electronic copy of a grant application to us. Upon receipt, IHS will administratively review applications by completeness and responsiveness. Applications that are incomplete, non-responsive to this RFA, do not meet eligibility criteria or do not follow the guidelines of the SF 424 will be returned to the applicant without further consideration. Applications will be evaluated for technical merit by appropriate peer review groups convened by the IHS National Diabetes Program in accordance with established criteria.
Applicants will only be eligible to receive one award for funding in one area (i.e. primary prevention of diabetes or prevention of cardiovascular disease in people with diabetes. Priorities for funding will be based on the technical merit of the application, the assessed potential of the applicant and the likelihood of the applicant to successfully implement the defined interventions. Awards will be made only to organizations with financial management systems and management capabilities that are acceptable under PHS Policy. Awards will be administered under the PHS Grants Policy Statement. Awards will be subject to the availability of funds and grants will be administered in accordance with applicable Office of Management and Budget (OMB) Circulars, Department of Health and Human Services grant regulations at 45 CFR Parts 74 and 92, the Public Health Service Grants Policy Statement and other applicable IHS polices and procedures such as the regulations governing protection of human subjects at 45 CFR Part 46. Grants Management will not award a grant without an approved application in conformance with regulatory and policy requirements and which describes the purpose and scope of the project to be funded. When the application is approved for funding, the Grants Management Office will prepare a Notice of Grant Award with special terms and conditions binding upon the award and refer to all general terms applicable to the award.
Prospective applicants are asked to submit a letter of intent that includes the selected area for the application (primary prevention of diabetes or prevention of CVD in people with diabetes), the name, address, and telephone number of the Project Director and its Program Coordinator, and the number and title of this RFA. The letter of intent must be received by the IHS National Diabetes Program, 5300 Homestead Road NE, Albuquerque, NM 87110, telephone 505-248-4182, fax 505-248-4188, email: firstname.lastname@example.org, before 6:00 pm MDT on June 1, 2008. Letters may be submitted by mail, fax, or email. Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows the IHS staff to estimate the potential review workload and avoid conflict of interest in the review. Application and Resolution Date: July 1, 2008. The applications must be received before 6:00 pm MDT on July 1, 2008. If an application is received after that date, it will be returned to the applicant without review. To be considered timely, an application must be received on or before the deadline date. No additional materials received after the deadline will be considered. Applications not meeting the deadline date specified in the announcement are considered late applications and will not be considered for funding under the announcement. Receipt of applications will be acknowledged by postcard.
Balanced Budget Act of 1997, Public Law 105-33; Consolidated Appropriations Act 2001, Public Law 106-554; Reauthorization of SDPI 2002, Public Law 107-360.
Range of Approval/Disapproval Time
The anticipated date for the announcement of selectees is 60 days after the application due date.
This funding will be awarded as a grant, renewable annually for up to 5 years. The HIS National Diabetes Program will determine if grants are renewable after 5 years depending on funding levels and congressional actions.
Formula and Matching Requirements
Length and Time Phasing of Assistance
There will be only one funding cycle for FY 2004 - FY 2008. This funding will be awarded as a grant, renewable annually for up to 5 years. Awards under this initiative will be administered using the competing institutional grant mechanism of the Indian Health Service. Applicants should request the first year as a planning year, and the next 4 years as full implementation of demonstration project activities.
Post Assistance Requirements
Given the importance of the outcomes of this demonstration project to future funding of the Special Diabetes Program for Indians, particular emphasis will be placed on the timely and comprehensive reporting of results through a variety of mechanisms.
The IHS NDP and the Grants Management Office have requirements for the progress reports and financial reports based on the terms and conditions of these grant.
Grantees are responsible and accountable for accurate reporting of the Progress Reports and Financial Status Reports which are generally due annually.
Financial Status Report (SF 269) is due 90 days after each budget period and the final SF 269 must be verified from the grantee records on how the value was derived.
Grantees are allowed a reasonable period of time in which to submit required financial and performance reports.
Failure to submit required reports within the time allowed may result in suspension or termination of an active grant, withholding of additional awards for the project, or other enforcement actions such as withholding of payments or converting to the reimbursement method of payment.
Continued failure to submit required reports may result in the imposition of special award provisions, or cause other eligible projects or activities involving the grant recipient, or the individual responsible for the delinquency to not be funded.
Progress reports will be required on an annual basis.
In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments and Nonprofit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials.
Financial records of the grant must be retained for 3 years after submission of the final expenditure report. If questions remain, such as those resulting from an audit, pertinent records must be kept until the matter is resolved. The Secretary, the Inspector General of the Department of the Health and Human Services, and the Comptroller General of the United States or any of their authorized representatives shall have the right to access all records, report, books, document, papers or other records of the grantee, contractor, or subcontractor or of any entity pertinent to the DHHS grant in order to make audits, examinations, excerpts and transcripts.
(Competitive Grant) FY 07 $23,300,000; FY 08 $23,300,000; and FY 09 est not available.
Range and Average of Financial Assistance
The total amount of funding available is $23,300,000 and the number of anticipated awards will be approximately 60 (30 in each intervention area). The expected amount of individual awards will vary based on size of the program, and will vary from $200,000 to $300,000 per year.
Regulations, Guidelines, and Literature
45 CFR 92 and 45 CFR 74; Public Health Service Grants Policy Statement, DHHS Publication No. (OASH) 94-50,000 (Rev.) April 1, 1994.
Regional or Local Office
Program Contact: Dr Kelly Acton or Lorraine Valdez, BSN, MPA, CDE IHS National Diabetes Program 5300 Homestead Road NE Albuquerque, NM 87110 Telephone 505-248-4182 Fax 505-248-4188 Email: email@example.com Grants Management Office Contact: Ms. Kimberly Pendleton, Senior Grants Management Officer, Division of Grants Operations, Indian Health Service, 801 Thompson Avenue, TMP, Suite 360 Rockville, MD 20852. Telephone: 301-443-5204, Fax 301-443-9602.
Criteria for Selecting Proposals
Applications will be evaluated in accordance with the criteria stated below for technical merit by appropriate peer review groups convened by the IHS National Diabetes Program. Applications will be reviewed and scored according to the quality of their responses to the requirements listed below for developing the project narrative: 1) statement of need, 2) proposed implementation approach, 3) management plan and staffing, and 4) evaluation plan. The IHS National Diabetes Program will convene 2 review groups, one for each area in this initiative. The recommendations from the review committees will be considered by the IHS NDP. The Director of the IHS NDP will make the final funding decisions in consideration of the following points, some of which were based on input from the tribal consultation: strengths and weaknesses of the application as identified by peer reviewers, likelihood of success in implementation of the activities, demonstrated capacity of the applicant for programmatic implementation, availability of funds, and other factors based on tribal consultation including distribution of awards in terms of geography and balance among program size, program type (i.e. IHS, Tribal, urban vs. rural, hospital, clinic, etc.) Awards will be made only to organizations with financial management systems and management capabilities that are acceptable under PHS Policy. Awards will be administered under the PHS Grants Policy Statement.
Co-founders William Mann and David Mravyan devised the Sensimat during a mandatory project for their MBA at the Richard Ivey School of Business in Canada. Sensimat is a device that helps manage and assess pressure among wheelchair users.